Your session is about to expire
← Back to Search
Exercise for Healthy Aging (COMET Trial)
COMET Trial Summary
This trial will test whether recommended levels of exercise improve cognition in older adults.
COMET Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCOMET Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.COMET Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a reliable way to get to my appointments.I do not have a major psychiatric illness or condition affecting my brain that could impact thinking tests.I am between 65 and 80 years old.I haven't changed my blood pressure medication in the last 2 months.You have received treatment for alcohol or drug abuse within the past two years.You regularly do intense strength training exercises at least twice a week.I haven't had cancer treatment in the last 2 years, except for a localized cancer.My joint pain stops me from walking, lifting objects, or gets worse with more activity.I am between 65 and 80 years old.I use a device to help me walk.I am currently using insulin.I've had a head injury that made me lose consciousness for more than a few minutes.I have a dependable way to get to my appointments.I cannot or will not undergo an MRI.I have not had treatments for heart issues like atrial fibrillation or stent placement in the last 2 years.I have a health condition that may make it unsafe for me to exercise.I have had heart disease, failure, attack, surgery, or chest pain with effort in the last 2 years.I am between 65 and 80 years old.
- Group 1: Weight Training
- Group 2: Core and Fusion Training
- Group 3: Combined Endurance and Weight Training
- Group 4: Endurance Training
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How do I qualify to participate in this research?
"In order to qualify for this study, elderly adults must be in good health and within the age range of 65 to 80 years old. Up to 280 patients will be accepted in total."
How many people are being treated as part of this research?
"That is accurate, the clinical trial in question is still recruiting patients. According to the information on clinicaltrials.gov, which was last updated on 9/6/2022, the study originally began recruitment on 10/14/2021 and is looking for 280 participants at 1 site."
Are there any patients currently needed for this research?
"That is correct, the clinical trial mentioned is still recruiting patients. According to information on clinicaltrials.gov, the posting date was October 14th 2021 and the most recent update was September 6th 2022. Only 1 site is needed for this study as it enrolling a total of 280 people."
Are patients who are 45 years or older being accepted into this trial?
"The lower age limit for this clinical trial is 65 years old and the upper age limit is 80 years old."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of Kansas Alzheimer's Disease Center: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger